Philips Medical Systems (Cleveland), Inc. v. Buan

District Court, N.D. Illinois·Decided July 28, 2021·No. 1:19-cv-02648·Unknown

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

PHILIPS MEDICAL SYSTEMS ) (CLEVELAND), INC. and PHILIPS ) MEDICAL SYSTEMS DMC, GmbH, ) ) Plaintiffs, ) ) No. 19-cv-02648 v. ) ) Judge Marvin E. Aspen JOSE BUAN, GL LEADING ) TECHNOLOGIES, INC., KUNSHAN ) YIYUAN MEDICAL TECHNOLOGY CO., ) LTD., KUNSHAN GUOLI ELECTRONIC ) TECHNOLOGY CO., LTD., and ) SHERMAN JEN, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER MARVIN E. ASPEN, District Judge: Plaintiffs Philips Medical Systems (Cleveland), Inc. (“Philips Cleveland”) and Philips Medical Systems DMC, GmbH (“Philips Germany”) have brought suit against Defendants Jose Buan, GL Leading Technologies, Inc. (“GL Leading”), Kunshan Yiyuan Medical Technology Co., Ltd. (“Yiyuan”), Kunshan GuoLi Electronic Technology Co., Ltd. (“GuoLi”), and Sherman Jen, alleging that Defendants misappropriated trade secrets and confidential information pertaining to the development and production of X-ray tubes that are used in medical imaging machines. In light of another lawsuit brought by Plaintiffs against them in China, Yiyuan and GuoLi (collectively, the “Kunshan Defendants”) now move to dismiss Plaintiffs’ claims against them in this litigation on forum non conveniens grounds or, alternatively, to stay the claims based on the abstention doctrine set forth in Colorado River Water Conservation District v. United States, 424 U.S. 800, 96 S. Ct. 1236 (1976). (Dkt. No. 285, Mot. to Dismiss; Dkt. No. 286, Mem. in Supp. of Mot. to Dismiss (“Mem.”).) Plaintiffs oppose the motion.1 (Dkt. No. 294, Pls.’ Opp’n to Mot. to Dismiss (“Opp’n”).) For the following reasons, we deny the Kunshan Defendants’ motion in its entirety. FACTUAL BACKGROUND We take the following facts from the pleadings, other filings in this case, and the

materials submitted or identified by Plaintiffs and the Kunshan Defendants in briefing this motion. Unless contradicted by other evidence in the record, we have accepted the allegations in Plaintiffs’ Second Amended Complaint (the operative complaint) as true for purposes of this motion. See Deb v. SIRVA, Inc., 832 F.3d 800, 809 (7th Cir. 2016) (forum non conveniens motion); Loughran v. Wells Fargo Bank, N.A., No. 19 C 4023, 2019 WL 6349890, at *2 (N.D. Ill. Nov. 27, 2019) (Colorado River abstention motion), aff’d, 2 F.4th 640 (7th Cir. 2021). Philips Cleveland is a California corporation with its principal place of business in Cleveland, Ohio. (Dkt. No. 92, Second Am. Compl. (“SAC”), ¶ 1.)2 Philips Germany is a German entity with its principal place of business in Hamburg, Germany. (Id. ¶ 2.) Plaintiffs engage in “research, development, and commercialization of medical imaging technology.” (Id.

¶ 3.) In October 2001, Philips Cleveland acquired “a company with a facility in Aurora, Illinois that designed, manufactured, and distributed X-ray tubes for OEM and replacement

1 Plaintiffs filed their opposition and certain accompanying exhibits under seal. If we refer to a sealed document, we attempt to do so without revealing any information that could be reasonably deemed confidential. Nonetheless, to the extent we discuss confidential information, we have done so because it is necessary to explain the path of our reasoning. See In re Specht, 622 F.3d 697, 701 (7th Cir. 2010) (“Documents that affect the disposition of federal litigation are presumptively open to public view, even if the litigants strongly prefer secrecy, unless a statute, rule, or privilege justifies confidentiality.”); Union Oil Co. of Cal. v. Leavell, 220 F.3d 562, 568 (7th Cir. 2000) (explaining that a judge’s “opinions and orders belong in the public domain”).

2 For ECF filings, we cite to the page number(s) set forth in a document’s ECF header unless citing to a particular paragraph or other page designation is more appropriate. applications.” (Id. ¶¶ 24, 25.) Philips Cleveland thereafter designed and manufactured X-ray tubes at the Aurora facility for Philips Germany. (Id. ¶ 64.) By the end of 2017, however, Plaintiffs had closed the Aurora facility and transferred the facility’s operations to Hamburg, Germany. (See Dkt. No. 158-1, Ex. 1 to GuoLi’s May 18, 2020 Mot. to Dismiss, at 2–3; Dkt.

No. 158-4, May 18, 2020 Decl. of Xiaoqin Du (“Du Decl.”), ¶ 10.) GuoLi and Yinyuan are Chinese corporations with their principal places of business in Kunshan, Jiangsu Province, China. (SAC ¶¶ 7, 9; Mem. at 4.) By the end of 2013, GuoLi had established a medical X-ray tube division, and in February 2014, it began developing a medical X-ray tube product known as GLA2153. (Du Decl. ¶ 4.) In May 2018, GuoLi formed Yinyuan “to focus on the medical x-ray vacuum tube business,” and it transferred its medical X-ray business, including its work on GLA2153, to Yiyuan. (Id. ¶¶ 6–7; Dkt. No. 161-3, May 16, 2020 Decl. of Feng Zhou (“Zhou Decl.”), ¶ 4; Dkt. No. 210-5, July 16, 2020 Suppl. Decl. of Feng Zhou (“Suppl. Zhou Decl.”), ¶ 4.) GuoLi does not have any employees in Illinois or facilities in the United States, and it has not sold any medical X-ray tubes in the United States. (Dkt. No.

158-3, May 16, 2020 Decl. of Hao Huang (“Huang Decl.”), ¶ 5.) Yiyuan does not have any employees or facilities in the United States, and it has never sold any products in the United States. (Zhou Decl. ¶ 5.) GL Leading is an Illinois corporation with its headquarters and principal place of business in Aurora, Illinois. (SAC ¶ 5.) GL Leading was established in late 2017 as a company to consult in the design of replacement and OEM components for medical imaging equipment. (Id. ¶¶ 6, 98.) GL Leading provided consulting services first to GuoLi, and then to Yiyuan after Yiyuan’s formation. (Du Decl. ¶¶ 12, 24; Suppl. Zhou Decl. ¶ 7.) GuoLi and Yiyuan have been GL Leading’s only customers. (Dkt. No. 210-3, July 17, 2020 Suppl. Decl. of Xiaoqin Du (“Suppl. Du Decl.”), ¶ 14.) GL Leading’s services to GuoLi and Yiyuan involved the design of X-ray tube products. (Du Decl. ¶¶ 8, 12.) In early 2018, GL Leading reviewed GuoLi’s designs for GLA2153 and

provided comments and suggested improvements to the designs. (Dkt. No. 193-26, GL Leading’s 3d Am. Resps. to Pls.’ 1st Set of Interrogs., at 12; Suppl. Du Decl. ¶ 10; Dkt. No. 210- 4, July 16, 2020 Decl. of Shiqiang Xu (“Xu Decl.”), ¶ 4.) GL Leading also participated in designing another X-ray tube, YY8019, which Yiyuan began developing in 2019. (Du Decl. ¶ 8; GL Leading’s 3d Am. Resps. to Pls.’ 1st Set of Interrogs. at 12 (asserting that GL Leading used “parts from the GLA2153 tube to create the YY8019 tube”).) When GL Leading provided services to GuoLi, GuoLi personnel visited GL Leading’s facility in Illinois several times. (See Suppl. Du Decl. ¶ 8.) Similarly, once GL Leading began providing services to Yiyuan, Yiyuan personnel frequently traveled to GL Leading’s facility to work with its personnel on projects. (Suppl. Zhou Decl. ¶ 2.) In particular, “Yiyuan held monthly meetings with GL Leading

engineers” in the second half of 2018 “to understand GL Leading’s progress with projects it was working on for Yiyuan and to ensure that GL Leading was making sufficient progress.” (Suppl. Du Decl. ¶ 13.) Yiyuan and GL Leading also share a file folder that engineers from both companies can access to upload and download technical documents for the projects they work on with each other. (Suppl. Zhou Decl. ¶ 5.) Defendant Jose Buan is an Illinois citizen. (SAC ¶ 4.) Defendant Sherman Jen lives in Wisconsin but regularly conducts business in Illinois. (Id. ¶ 11; Dkt. No. 69-1, GL Leading’s 2d Am. Resps.

Free access — add to your briefcase to read the full text and ask questions with AI

Philips Medical Systems (Cleveland), Inc. v. Buan, (N.D. Ill. 2021).

Philips Medical Systems (Cleveland), Inc. v. Buan (Philips Medical Systems (Cleveland), Inc. v. Buan) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Gulf Oil Corp. v. Gilbert
330 U.S. 501 (Supreme Court, 1947)
In Re Specht
622 F.3d 697 (Seventh Circuit, 2010)
R. Maganlal & Company v. M.G. Chemical Company, Inc.
942 F.2d 164 (Second Circuit, 1991)
Huon v. Johnson & Bell, Ltd.
657 F.3d 641 (Seventh Circuit, 2011)
Union Oil Company of California v. Dan Leavell
220 F.3d 562 (Seventh Circuit, 2000)
Hyatt International Corp. v. Gerardo Coco
302 F.3d 707 (Seventh Circuit, 2002)
Clerides v. Boeing Co.
534 F.3d 623 (Seventh Circuit, 2008)
U.S.O. Corp. v. Mizuho Holding Co.
547 F.3d 749 (Seventh Circuit, 2008)
Abad v. Bayer Corp.
563 F.3d 663 (Seventh Circuit, 2009)
Narducci v. Moore
572 F.3d 313 (Seventh Circuit, 2009)